4-Methoxycinnamic acid

4-Methoxycinnamic acid (CAS No.: 830-09-1) is a naturally occurring phenylpropanoid and phenolic acid widely studied for its diverse biological activities in biomedical research and drug discovery. As a plant-derived metabolite identified in species such as A. preissii, it exhibits antioxidant properties that modulate intracellular oxidative stress and influence inflammation-associated signaling pathways, making it a useful tool for investigating redox regulation and inflammatory responses. Experimental evidence indicates that this compound can inhibit microbial biofilm formation at millimolar concentrations and exert metabolic and chemopreventive effects in vivo, including attenuation of dysplastic lesions in carcinogenesis models and reduction of hyperglycemia in diabetes models, suggesting involvement in pathways related to cell proliferation, apoptosis, and metabolic homeostasis. Additionally, its ability to reverse cognitive deficits in neuropharmacological models highlights potential neuromodulatory mechanisms. In vitro and in vivo studies typically employ concentrations ranging from low micromolar to millimolar levels or dose regimens adjusted according to specific experimental paradigms. Consequently, 4-Methoxycinnamic acid serves as a valuable small molecule probe for studying mechanisms underlying inflammation, metabolic disorders, microbial pathogenicity, and cancer-related processes in cell-based assays and preclinical models.